BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31405946)

  • 1. Human CD4
    Longino NV; Yang J; Iyer JG; Ibrani D; Chow IT; Laing KJ; Campbell VL; Paulson KG; Kulikauskas RM; Church CD; James EA; Nghiem P; Kwok WW; Koelle DM
    Cancer Immunol Res; 2019 Oct; 7(10):1727-1739. PubMed ID: 31405946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
    Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P
    Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8
    Jing L; Ott M; Church CD; Kulikauskas RM; Ibrani D; Iyer JG; Afanasiev OK; Colunga A; Cook MM; Xie H; Greninger AL; Paulson KG; Chapuis AG; Bhatia S; Nghiem P; Koelle DM
    Cancer Immunol Res; 2020 May; 8(5):648-659. PubMed ID: 32179557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.
    Lyngaa R; Pedersen NW; Schrama D; Thrue CA; Ibrani D; Met O; Thor Straten P; Nghiem P; Becker JC; Hadrup SR
    Clin Cancer Res; 2014 Apr; 20(7):1768-78. PubMed ID: 24526738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
    Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
    Clin Cancer Res; 2011 Jul; 17(14):4806-13. PubMed ID: 21642382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine 220 phosphorylation of the Merkel cell polyomavirus large T antigen crucially supports growth of Merkel cell carcinoma cells.
    Schrama D; Hesbacher S; Angermeyer S; Schlosser A; Haferkamp S; Aue A; Adam C; Weber A; Schmidt M; Houben R
    Int J Cancer; 2016 Mar; 138(5):1153-62. PubMed ID: 26383606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
    Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
    Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
    Miller NJ; Church CD; Fling SP; Kulikauskas R; Ramchurren N; Shinohara MM; Kluger HM; Bhatia S; Lundgren L; Cheever MA; Topalian SL; Nghiem P
    J Immunother Cancer; 2018 Nov; 6(1):131. PubMed ID: 30482247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells.
    Hesbacher S; Pfitzer L; Wiedorfer K; Angermeyer S; Borst A; Haferkamp S; Scholz CJ; Wobser M; Schrama D; Houben R
    Oncotarget; 2016 May; 7(22):32956-68. PubMed ID: 27121059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.
    Afanasiev OK; Yelistratova L; Miller N; Nagase K; Paulson K; Iyer JG; Ibrani D; Koelle DM; Nghiem P
    Clin Cancer Res; 2013 Oct; 19(19):5351-60. PubMed ID: 23922299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development.
    Tabachnick-Cherny S; Pulliam T; Church C; Koelle DM; Nghiem P
    Mol Carcinog; 2020 Jul; 59(7):807-821. PubMed ID: 32219902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival.
    Miller NJ; Church CD; Dong L; Crispin D; Fitzgibbon MP; Lachance K; Jing L; Shinohara M; Gavvovidis I; Willimsky G; McIntosh M; Blankenstein T; Koelle DM; Nghiem P
    Cancer Immunol Res; 2017 Feb; 5(2):137-147. PubMed ID: 28093446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into anti-tumor immunity
    Jani S; Church CD; Nghiem P
    Front Immunol; 2023; 14():1172913. PubMed ID: 37287968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merkel cell polyomavirus and non-Merkel cell carcinomas: guilty or circumstantial evidence?
    Csoboz B; Rasheed K; Sveinbjørnsson B; Moens U
    APMIS; 2020 Feb; 128(2):104-120. PubMed ID: 31990105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.
    Chapuis AG; Afanasiev OK; Iyer JG; Paulson KG; Parvathaneni U; Hwang JH; Lai I; Roberts IM; Sloan HL; Bhatia S; Shibuya KC; Gooley T; Desmarais C; Koelle DM; Yee C; Nghiem P
    Cancer Immunol Res; 2014 Jan; 2(1):27-36. PubMed ID: 24432305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice.
    Verhaegen ME; Mangelberger D; Harms PW; Vozheiko TD; Weick JW; Wilbert DM; Saunders TL; Ermilov AN; Bichakjian CK; Johnson TM; Imperiale MJ; Dlugosz AA
    J Invest Dermatol; 2015 May; 135(5):1415-1424. PubMed ID: 25313532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LAMP1 targeting of the large T antigen of Merkel cell polyomavirus results in potent CD4 T cell responses and tumor inhibition.
    Buchta Rosean C; Leyder EC; Hamilton J; Carter JJ; Galloway DA; Koelle DM; Nghiem P; Heiland T
    Front Immunol; 2023; 14():1253568. PubMed ID: 37711623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus.
    Gavvovidis I; Leisegang M; Willimsky G; Miller N; Nghiem P; Blankenstein T
    Clin Cancer Res; 2018 Aug; 24(15):3644-3655. PubMed ID: 29669806
    [No Abstract]   [Full Text] [Related]  

  • 19. Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes.
    Kumar S; Xie H; Shi H; Gao J; Juhlin CC; Björnhagen V; Höög A; Lee L; Larsson C; Lui WO
    Int J Cancer; 2020 Mar; 146(6):1652-1666. PubMed ID: 31180579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients.
    Paulson KG; Carter JJ; Johnson LG; Cahill KW; Iyer JG; Schrama D; Becker JC; Madeleine MM; Nghiem P; Galloway DA
    Cancer Res; 2010 Nov; 70(21):8388-97. PubMed ID: 20959478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.